All News ARCA biopharma, Inc.

Equities

ABIO

US00211Y5069

Real-time Estimate Cboe BZX Other stock markets 03:19:48 2024-05-15 pm EDT			5-day change	1st Jan Change
3.755 ^USD	+13.10%		+9.84%	+117.09%

Apr. 25	ARCA biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 19	North American Morning Briefing : Stock Futures -2-	DJ

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ARCA BIOPHARMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ARCA biopharma, Inc. - ABIO	May. 10	BU
ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update	Apr. 25	AQ
ARCA biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
North American Morning Briefing : Stock Futures -2-	Apr. 19	DJ
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of ARCA Biopharma, Inc. - ABIO	Apr. 09	PR
ARCA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ARCA biopharma, Inc. - ABIO	Apr. 05	BU
ARCA biopharma, Inc. Announces Management Changes	Apr. 04	CI
ARCA biopharma, Inc. Announces Separation of Michael Bristow, Chief Executive Officer	Apr. 04	CI
Sector Update: Health Care Stocks Softer Late Afternoon	Apr. 03	MT
Shareholder Alert: Ademi LLP investigates whether ARCA biopharma, Inc. has obtained a Fair Price in its transaction with Oruka	Apr. 03	PR
Top Midday Gainers	Apr. 03	MT
Sector Update: Health Care Stocks Rise Wednesday Afternoon	Apr. 03	MT
Sector Update: Health Care	Apr. 03	MT
ARCA biopharma, Oruka Therapeutics Announce All-Stock Merger; Shares Surge	Apr. 03	MT
ABIO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of ARCA Biopharma, Inc. Is Fair to Shareholders	Apr. 03	BU
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement	Apr. 03	AQ
Oruka Therapeutics announced that it expects to receive $275 million in funding	Apr. 02	CI
ARCA biopharma Announces 2023 Financial Results	Feb. 01	AQ
ARCA biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 01	CI
ARCA biopharma Announces Third Quarter 2023 Financial Results	23-10-18	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News ARCA biopharma, Inc.

Equities

ABIO

US00211Y5069

All News

Filters